Our Recommendations
- Déclaration sur l’efficacité du vaccin COVID-19 d’AstraZeneca (ChAdOx1 nCoV-19) contre les variants du SARS-CoV-2 (2021)
- Guidance for surveillance of SARS-CoV-2 variants: Interim guidance, 9 August 2021 (2021)
- Variants (2021)
- COVID Reference 2021.6 EN (2021)
- Statement on the Efficacy of the AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-19) against the SARS-CoV-2 Variants (2021)
New Publications
- Update 80: What we know about new COVID-19 Variants of Concern - the latest on the global situation & Omicron BA.4/5 (2022)
- Special Focus: Update on SARS-CoV-2 Variants of Interest and Variants of Concern (2022)
- Emerging SARS-CoV-2 Variants (2021)
- Standard Operating Procedure for Epidemiological Surveillance & Response for the new variant of SARS-CoV-2 in the context of regulated resumption of limited flights originating from United Kingdom (UK (2021)
- WHO Science in 5 Episode #20 - COVID-19 - Variants & Vaccines (2021)
Filter
37
Featured
Recommendations
8
Language
Document type
Fact sheets
17
Guidelines
6
Videos
6
Studies & Reports
3
Training Material
2
Resource Platforms
2
Manuals
1
Countries / Regions
Russia
3
Niger
2
Germany
2
West and Central Africa
2
France
2
Spain
2
East and Southern Africa
2
South Africa
2
Brazil
2
Mali
2
South Sudan
2
Colombia
1
Mexico
1
El Salvador
1
Turkey
1
Benin
1
Kazakhstan
1
Chile
1
Cameroon
1
Syria
1
Senegal
1
Congo-Brazzaville
1
Burkina Faso
1
Peru
1
Morocco
1
Qatar
1
Mauritania
1
Mozambique
1
Haiti
1
Dominican Republic
1
Venezuela
1
Latin America and the Carribbean
1
Jordan
1
Saudi Arabia
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Lebanon
1
Vietnam
1
Eastern Europe
1
Nicaragua
1
Egypt
1
Sudan
1
Yemen
1
Honduras
1
Chad
1
Libya
1
Iraq
1
Somalia
1
Ecuador
1
India
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
COVID-19
14
Guidelines
1
Toolboxes
SARS-CoV-2 Variants
37
Surveillance & Contact tracing
5
Video & Audio
3
Country specific documents
3
Videos
3
Training, others
2
Communication Material
2
Vaxzevria (Astra Zeneca)
2
Clinical Guidelines
1
Prevention & Preparedness
1
Clinical Aspects
1
Public Health
1
Diagnostics & Laboratory Guidance
1
Scientific & Research Studies
1
Information for the Public
1
Vaccine Candidates & Research
1
Immunization Guidelines
1
Non-pharmaceutical interventions (NPIs)
1
Logistics & Supply
1
COVAX Initiative
1
Research & Pipeline
1
COVID Reference 2021.6 EN
recommended
6th edition 13 January 2021 CR 2021.6.10, uploaded on 27 May 2021
Find eight editions: Deutsch | English | Español | Français | Italiano | Português | Tiếng Việt | Türkçe
https://covidreference.com/download
Vertreter besorgniserregender Virusvarianten (variants of concern, kurz VOC) wurden weltweit aber auch in Europa, identifiziert. Molekularbiologische Details zu den Varianten sind unter SARS-CoV-2: Virologische Basisdaten und Virusvarianten abrufbar.
A COVID-19 virus mutation tracker system (CovMT; appendix) based on SARS-CoV-2 isolate genomes deposited to GISAID to track the worldwide sequencing efforts and the evolution of the mutational landscape of this virus. CovMT, which is updated daily, summarises mutations from more than 450 000 isola...
Weekly epidemiological update on COVID-19, 28 September 2022
What are the variants circulating at this time? How are variants classified as variants of interest or concern? What does this mean for the public? Dr Maria Van Kerkhove explains in Science in 5 this week.
Do the current batch of approved vaccines protect us from the Delta variant? What is the level of protection? If you can still get infected even after being fully vaccinated, then why should we vaccinate? WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5.
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators ...
Cet article fait partie d’une série de notes explicatives sur la mise au point et la distribution de vaccins.
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators ...
Orientations provisoires
9 août 2021
Le présent document vise à décrire un ensemble minimal d'activités de surveillance recommandées au niveau national pour détecter et surveiller la prévalence relative des variantes du SRAS-CoV-2 et à présenter un ensemble d'activités pour la caractér...
Временные рекомендации
9 августа 2021 г.
Цель данного документа - описать минимальный набор мероприятий по эпиднадзору, рекомендуемых на национальном уровне для вы...
Orientaciones provisionales
9 de agosto de 2021
El presente documento tiene por objeto describir un conjunto mínimo de actividades de vigilancia recomendadas a nivel nacional para detectar y supervisar la prevalencia relativa de las variantes del SRAS-CoV-2 y esbozar un conjunto de actividades pa...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Update on SARS-CoV-2 variant of concern Omicron
recommended
Update 70, 10 Dec. 2021
WHO’s Science in 5 Episode #63 - Omicron variant
recommended
What do we know about Omicron variant so far? WHO's Dr Maria Van Kerkhove updates on the transmissibility, severity, symptoms and ways to protect yourself in Science in 5.
If Omicron is less severe, why are people ending up in the hospital and dying from it? Is it true that everyone will eventually get Omicron? Why is it important to reduce transmission? WHO's Dr Maria Van Kerkhove explains in Science in 5.
Strengthening surveillance for Variant of Concern (VOC) Omicron (B.1.1.529): technical brief and priority actions for member states World Health Organization Headquarters, 28 November 2021
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulat...
